Zobrazeno 1 - 10
of 525
pro vyhledávání: '"Antiandrogen therapy"'
Autor:
Chia-Hui Chen, Boyang Jason Wu
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Monoamine oxidase A (MAOA), a mitochondrial enzyme degrading biogenic and dietary amines, has been studied in the contexts of neuropsychiatry and neurological disorders for decades, but its importance in oncology, as best exemplified in prostate canc
Externí odkaz:
https://doaj.org/article/1a2aa4de540e4478ae872b2cefe975f6
Autor:
Belén Congregado Ruiz, Inés Rivero Belenchón, Guillermo Lendínez Cano, Rafael Antonio Medina López
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1105 (2023)
Since prostate cancer (PCa) was described as androgen-dependent, the androgen receptor (AR) has become the mainstay of its systemic treatment: androgen deprivation therapy (ADT). Although, through recent years, more potent drugs have been incorporate
Externí odkaz:
https://doaj.org/article/bbe573eafb7849f59fb1c786b230f2df
Autor:
Emma Zattarin, Federico Nichetti, Francesca Ligorio, Laura Mazzeo, Riccardo Lobefaro, Giovanni Fucà, Giorgia Peverelli, Andrea Vingiani, Giulia V. Bianchi, Giuseppe Capri, Filippo de Braud, Claudio Vernieri
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Extramammary Paget disease (EMPD) is a rare form of cutaneous, intraepithelial adenocarcinoma, which typically presents itself as an erythematous plaque originating from apocrine-gland rich regions, such as the vulva, the perianal region, the scrotum
Externí odkaz:
https://doaj.org/article/02ed4f0921e249db898877b9b34d54a9
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Male occult triple-negative breast cancer (TNBC) is an exceedingly rare form of breast cancer, and prospective information regarding its management is therefore lacking. Current treatment strategies are largely extrapolated from clinical trials of fe
Externí odkaz:
https://doaj.org/article/072e54b9f1964d889e383144919ea767
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ekrama, Basel Amadeus
Hintergrund: Das lokal fortgeschrittene Prostatakarzinom (PCa) zeichnet sich durch eine erschwerte Operabilität und ein erhöhtes Risiko für positive Resektionsränder aus und stellt aufgrund des ungünstigen pathologischen und onkologischen Outcom
Externí odkaz:
https://tud.qucosa.de/id/qucosa%3A91808
https://tud.qucosa.de/api/qucosa%3A91808/attachment/ATT-0/
https://tud.qucosa.de/api/qucosa%3A91808/attachment/ATT-0/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Molecules, Vol 26, Iss 8, p 2228 (2021)
Prostate cancer is a very common disease, which is, unfortunately, often the cause of many male deaths. This is underlined by the fact that the early stages of prostate cancer are often asymptomatic. Therefore, the disease is usually detected and dia
Externí odkaz:
https://doaj.org/article/99bf29a027c144afb34462fccf09310e
Autor:
Neal D. Shore, Joyce Steinberg, Bertrand Tombal, Ugo De Giorgi, Xun Lin, Qi Shen, Fred Saad, David F. Penson, Katarzyna Madziarska, Jennifer Sugg, Cora N. Sternberg, Eleni Efstathiou, Maha Hussain, Karim Fizazi
Publikováno v:
European journal of cancer, Vol. 159, p. 237-246 (2021)
BACKGROUND: Enzalutamide combined with androgen deprivation therapy (ADT) significantly prolonged metastasis-free survival and overall survival (OS) versus ADT alone in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) with r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598f20d434a67b2946d729c4e157d26c
https://doi.org/10.1016/j.ejca.2021.10.015
https://doi.org/10.1016/j.ejca.2021.10.015
Autor:
Isaac E. Kim, Monish Aron, Thomas L. Jang, Daniel D. Kim, Saum Ghodoussipour, Mark N. Stein, Isaac Yi Kim, David Y. Lee, Marc A. Dall'Era, Eric A. Singer, Sinae Kim
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 7909-7920 (2021)
Cancer Medicine
Cancer Medicine
Since 2004, multiple blockbuster drugs have been approved for men with metastatic prostate cancer. Nevertheless, it has been reported that no improvement in survival was observed between 2004 and 2009. Herein, we have analyzed the SEER database to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a5dc5ad363afbeb5943f1367ec05234
https://doaj.org/article/f0308822a4d1411cbcaa1149414a27a7
https://doaj.org/article/f0308822a4d1411cbcaa1149414a27a7